Beqalzi (sonrotoclax) is the first BCL2 inhibitor indicated for MCL patients who have progressed after at least 2 lines of therapy, including a BTK inhibitor.

Two phase 3b trials evaluated the efficacy and safety of tirzepatide or orforglipron for weight maintenance after injectable incretin treatment.

Consumers are advised to discard a specific lot of MG217 eczema cream following reports of potential Staphylococcus aureus contamination.

HealthDay News — Telemedicine adoption is not associated with changes in visits or spending, according to a study published online May 11 in JAMA Network Open.

In all, 11 cases of hantavirus have been reported as of this morning. Nine have been confirmed to be Andes virus, with two others “probable,” World Health Organization (WHO) Director-General Tedros ...